S2-E14 - NASH-TAG Session 4 Summary: Basic Science and Promising Drugs on the Horizon
Send us a text Naim Alkhouri and Jörn Schattenberg join Roger and Donna to review the closing session of NASH-TAG 2021, a potpourri of basic science and review of promising drugs earlier in development. The Saturday afternoon closing session of NASH-TAG 2021 spends half its time discussing basic science issues and the other half with BioPharma company drug developers discussing their promising drugs in development. Last year, this session yielded some real fireworks! On Sunday, join SurfingNA...
15 Mars 202147min
S2-E13 - NASH-TAG Session 3 Summary: Trial Designs of the Future and the Future of Diabetes Drugs in NASH
Send us a text NASH-TAG Co-director Michael Charlton and Ian Rowe join Roger, Louise and Donna to review the morning that Michael himself identified as one of two highlight sessions of NASH-TAG 2021. The Saturday morning session of NASH-TAG 2021 envisions a world of clinical trials without biopsies, considers implications of enrolling co-morbid and other challenging patients, ands winds up with a debate about the role of diabetes drugs in the future of NASH therapies. After the session, join...
14 Mars 202149min
S2-E12 - NASH-TAG Session 2 Summary: Innovative Trial Design and Robust Histologic Analyses
Send us a text Jörn Schattenberg and Naim Alkhouri join the Surfers (including NASH-TAG co-director Stephen Harrison) to review NASH-TAG session to with its focus on innovative trial design and improving histological analyses. The Friday afternoon session of NASH-TAG 2021 highlights innovation in clinical trial design and histologic analysis. Before NASH-TAG starts its Day Two, join SurfingNASH to sort out how what the data means, how the pieces fit together and what questions will require m...
13 Mars 202148min
S2 E11 — NASH-TAG Session 1 summary: Major Drugs in Development and Why Trials Fail
Send us a text Manal Abdelmalek and Ian Rowe join Roger, Louise and Donna to review the morning that Vlad Ratziu and Michael Charlton both identified as the highlight session of NASH-TAG 2021. The Friday morning session of NASH-TAG 2021 highlights advancing research for five major NASH drugs in development, explores the question why drug trials fail and wraps up with a rapid-fire session on promising data. Surfers were excited about some of the new drugs and found the presentations fro...
12 Mars 202150min
S2 E10 — Before NASH-TAG, Conversations With Co-Directors
Send us a text NASH-TAG Co-directors Vlad Ratziu and Michael Charlton talk with Roger Green about the upcoming conference, after which Roger discusses the SurfingNASH coverage plan for NASH-TAG. If you listen to SurfingNASH, you already know exactly how Stephen Harrison feels about NASH-TAG and what lights him up about this year's agenda. Now, listen as two other co-directors, Vlad Ratziu and Michael Charlton, discuss how the meeting started, what makes it special and what they are looking f...
11 Mars 202140min
S2-E9.2—Drug-Free Treatment of Early Fatty Liver Disease: Issues for Public Health
Send us a text Donna Cryer joins the Surfers to consider some of the public health issues and implications surrounding treatment of Early Fatty Liver disease and related metabolic diseases. EXTRA: Louise Campbell discusses her public health-driven motivation to form Tawazun Health. This episode is sponsored by Echosens. Echosens is partnering with Chronwell and ModifyHealth to offer LIVErHEALTHY, an integrated program of non-invasive monitoring, technology-supported behavior support, n...
7 Mars 202112min
S2-E9.1—Drug-Free Treatment of Early Fatty Liver Disease: Identity matters
Send us a text Donna Cryer and Roger Green lead a conversation of why identity matters for patients trying to resolve fatty liver disease without medication, while Stephen Harrison and Louise Campbell discuss some of their methods for doing so. This episode is sponsored by Echosens. Echosens is partnering with Chronwell and ModifyHealth to offer LIVErHEALTHY, an integrated program of non-invasive monitoring, technology-supported behavior support, nutritional counseling and delivery of medica...
7 Mars 202112min
S2-E9.3 — Introducing LIVErHEALTHY: a program for patients with Early Fatty Liver disease
Send us a text Executives from Echosens, Chronwell and ModifyHealth join to introduce LIVErHEALTHY, their integrated program for early Fatty Liver disease that integrates non-invasive monitoring, technology-supported behavior support, nutritional counseling and delivery of medically-tailored meals. This episode is sponsored by Echosens. to introduce LIVErHEALTHY. Echosens is partnering with Chronwell and ModifyHealth to offer LIVErHEALTHY, an integrated program of non-invasive monitoring, t...
7 Mars 202132min
